An international research team at Icahn School of Medicine at Mount Sinai is testing a sugar-based tracer contrast agent to be used with positron emission tomography (PET) imaging to help identify dangerous inflammation and high-risk vulnerable atherosclerotic plaque inside vessel walls that causes acute heart attacks and strokes.

Three prostate cancer patients were among the first to receive treatment at the Provision Center for Proton Therapy in Knoxville, Tenn., the state’s first proton therapy center.

As the world becomes more wired and mobile devices offer instant access to email, apps and the Web, it is only natural this technology is migrating into the healthcare sector, where physicians are seeking workflows similar to what they are familiar with when using their devices during free time. In addition to anywhere access to patient records, mobile devices can enable new functionality, such as critical results communication, mobile radiology image viewing for referring physician access, electrocardiogram (ECG) waveform access for immediate ST segment elevation myocardial infarction (STEMI) or other emergency assessment, and the ability to view completed reports on the go.

Computed Tomography (CT) procedure rates have declined by an average annual 5.5 percent in the United States over the past two years, diverging from a previous decade-long growth trend, according to a survey conducted by IMV Medical Information Division.